TEST-EGFR-TISSUE
TEST-EGFR-TISSUE
The reagent kit is used in the examination of patients diagnosed with non-small cell lung cancer (NSCLC) to determine indications for targeted therapy with EGFR tyrosine kinase inhibitors and monitor response to them.
Advantages
- Detects 28 mutations of the EGFR gene.
Reagent kits cannot be used to diagnose any pathology and are intended only for qualitative determination of the EGFR gene mutation status to determine indications for targeted therapy.
Detection method
Real-time PCR
Analysis type
Qualitative
Samples
Formalin-fixed and paraffin-embedded tissue (FFPE blocks)
Analytical sensitivity
10 copies of the EGFR gene per 1 µl of the DNA solution
Sensirtivity
90,9 %
Specificity
94,3 %
Time per 1 analysis
60 minutes
Equipment
CFX96, DTPrime, Rotor-Gene Q, QuantStudio 5, LC96, Abbot m2000rt
Number of isolations
5 / 24
Transportation and
Storage conditions
Storage conditions
+2 …+8 °C 12 months
+15 …+25 °C 5 days
+15 …+25 °C 5 days
Designed by